A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin in Healthy Chinese Volunteers
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (what the body does to the
medication) and pharmacodynamics (the action of the medication on the body) of JNJ-28431754
(canagliflozin) and its main metabolites (break-down products) following 2 different doses of
canagliflozin in healthy Chinese volunteers. Safety and tolerability of canagliflozin will
also be assessed.